Table 1.
Participant ID | Age | Nadir CD4+T-cell count (cells/mm3) | Duration of virologic suppression (years) | CD4+ T-cell count (cells/mm3) | Percent CD4+ T-cells in lymphocytes |
---|---|---|---|---|---|
1 | 69 | 210 | 6.00 | 742 | 41.2 |
2 | 54 | 253 | 19 | 653 | 36.3 |
3 | 57 | 300 | 2 | 587 | 36.7 |
4 | 55 | NA | NA | 762 | 23.8 |
5 | 51 | 0 | 8 | 692 | 17.3 |
6 | 54 | 425 | 3 | 607 | 26.4 |
7 | 61 | 325 | 16 | 1022 | 29.2 |
8 | 58 | NA | NA | 632 | 23.4 |
9 | 50 | NA | NA | 1345 | 26.9 |
10 | 54 | 187 | 12 | 590 | 26.8 |
11 | 52 | 67 | 14 | 422 | 28.1 |
12 | 53 | 150 | 7 | 958 | 38.3 |
13 | 52 | 96 | 1 | 832 | 39.6 |
14 | 64 | NA | NA | 725 | 48.3 |
15 | 64 | 7 | 15 | 538 | 33.6 |
16 | 39 | 325 | 6 | 556 | 39.7 |
17 | 56 | NA | NA | 882 | 42 |
18 | 54 | 120 | 15 | 699 | 36.8 |
19 | 57 | 190 | 19 | 780 | 39 |
20 | 47 | NA | NA | 796 | 36.2 |
21 | 62 | 88 | 24 | 783 | 43.5 |
Median (Interquartile range) | 54 (52–58) | 187 (92–277) | 12 (6–16) | 725 (607–796) | 34 (27–40) |
NA, not available